Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nizar Mahlaoui

Showing results (1-10 of 163) with videos related to

Pageof 17
Sort By:
Paediatric Drugs|June 15, 2016
Managing Inflammatory Manifestations in Patients with Chronic Granulomatous DiseaseAlessandra Magnani, Nizar Mahlaoui
Frontiers in Immunology|September 3, 2024
Editorial: Transition care in primary immunodeficienciesSiobhan Oisin Burns, Nizar Mahlaoui
Soins. Pediatrie, Puericulture|July 15, 2017
Nizar Mahlaoui, Béatrice Langellier-Bellevue
La Revue Du Praticien|December 18, 2007
[Curing a congenital immunologic deficiency]Nizar Mahlaoui, Marina Cavazzana-Calvo
Frontiers in Epidemiology|August 27, 2024
Pitfalls in time-to-event analysis of registry data: a tutorial based on simulated and real casesMickaël Alligon, Nizar Mahlaoui, Olivier Bouaziz
Clinical and Experimental Immunology|July 16, 2024
Protecting children and adults with primary antibody deficiencies against common and emergent pathogens and non-infectious complicationsOlaf Neth, Nizar Mahlaoui, Charlotte Cunningham-Rundles
Best Practice & Research. Clinical Rheumatology|September 19, 2006
A child with a systemic febrile illness - differential diagnosis and managementMichaël Hofer, Nizar Mahlaoui, Anne-Marie Prieur
Hematology/Oncology Clinics of North America|January 29, 2013
Epidemiology of congenital neutropeniaJean Donadieu, Blandine Beaupain, Nizar Mahlaoui, et al.
Journal of Clinical Immunology|May 20, 2017
Advances in the Care of Primary Immunodeficiencies (PIDs): from Birth to AdulthoodNizar Mahlaoui, Klaus Warnatz, Alison Jones, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|June 27, 2022
Inborn errors of immunity caused by defects in the DNA damage response pathways: Importance of minimizing treatment-related genotoxicityBenjamin Fournier, Nizar Mahlaoui, Despina Moshous, et al.
Pageof 17

Showing results (1-10 of 163) with videos related to

Sort By:
Pageof 17
Paediatric Drugs|June 15, 2016
Managing Inflammatory Manifestations in Patients with Chronic Granulomatous DiseaseAlessandra Magnani, Nizar Mahlaoui
Frontiers in Immunology|September 3, 2024
Editorial: Transition care in primary immunodeficienciesSiobhan Oisin Burns, Nizar Mahlaoui
Soins. Pediatrie, Puericulture|July 15, 2017
Nizar Mahlaoui, Béatrice Langellier-Bellevue
La Revue Du Praticien|December 18, 2007
[Curing a congenital immunologic deficiency]Nizar Mahlaoui, Marina Cavazzana-Calvo
Frontiers in Epidemiology|August 27, 2024
Pitfalls in time-to-event analysis of registry data: a tutorial based on simulated and real casesMickaël Alligon, Nizar Mahlaoui, Olivier Bouaziz
Clinical and Experimental Immunology|July 16, 2024
Protecting children and adults with primary antibody deficiencies against common and emergent pathogens and non-infectious complicationsOlaf Neth, Nizar Mahlaoui, Charlotte Cunningham-Rundles
Best Practice & Research. Clinical Rheumatology|September 19, 2006
A child with a systemic febrile illness - differential diagnosis and managementMichaël Hofer, Nizar Mahlaoui, Anne-Marie Prieur
Hematology/Oncology Clinics of North America|January 29, 2013
Epidemiology of congenital neutropeniaJean Donadieu, Blandine Beaupain, Nizar Mahlaoui, et al.
Journal of Clinical Immunology|May 20, 2017
Advances in the Care of Primary Immunodeficiencies (PIDs): from Birth to AdulthoodNizar Mahlaoui, Klaus Warnatz, Alison Jones, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|June 27, 2022
Inborn errors of immunity caused by defects in the DNA damage response pathways: Importance of minimizing treatment-related genotoxicityBenjamin Fournier, Nizar Mahlaoui, Despina Moshous, et al.
Pageof 17